[HTML] frontiersin.org

[HTML][HTML] From barriers to novel strategies: smarter CAR T therapy hits hard to tumors

MB Khawar, F Ge, A Afzal, H Sun - Frontiers in Immunology, 2023 - frontiersin.org
Chimeric antigen receptor (CAR) T cell therapy for solid tumors shows promise, but several
hurdles remain. Strategies to overcome barriers such as CAR T therapy-related toxicities …
被引用次数：3 相关文章
[HTML] nih.gov

[HTML][HTML] From barriers to novel strategies: smarter CAR T therapy hits hard to tumors

MB Khawar, F Ge, A Afzal, H Sun - Frontiers in Immunology, 2023 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cell therapy for solid tumors shows promise, but several
hurdles remain. Strategies to overcome barriers such as CAR T therapy-related toxicities …

From barriers to novel strategies: smarter CAR T therapy hits hard to tumors.

MB Khawar, F Ge, A Afzal, H Sun - Frontiers in Immunology, 2023 - europepmc.org
Chimeric antigen receptor (CAR) T cell therapy for solid tumors shows promise, but several
hurdles remain. Strategies to overcome barriers such as CAR T therapy-related toxicities …

From barriers to novel strategies: smarter CAR T therapy hits hard to tumors

MB Khawar, F Ge, A Afzal… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cell therapy for solid tumors shows promise, but several
hurdles remain. Strategies to overcome barriers such as CAR T therapy-related toxicities …

[引用][C] From barriers to novel strategies: smarter CAR T therapy hits hard to tumors

MB Khawar, F Ge, A Afzal, H Sun - 2023 - europepmc.org
Malignant tumors, despite the potency of chemotherapy, remain a resilient adversary and
are adept at evading traditional treatment methods, much like a wily fox. Regarding the fact …